510(k) Report

510(k) · Cleared

Cleared

Thoraguard System

K181667510(k) TraditionalCleared Nov 29, 2018157-day reviewClass II21 CFR 878.4780

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Centese, Inc. · BTA Pump, Portable, Aspiration (Manual Or Powered)

Cleared on Nov 29, 2018 as substantially equivalent to K141553 (Medela AG, 2014) after a 157-day review. Its family tree reaches back 6 generations to 1994. 1 of the 10 devices in its family, counting itself, has a Class I recall.

Decided
Nov 29, 2018
Review
157 days
Class
Class II
Product code
BTA
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K933902 (1994). 9 ancestors in all. No later device cites it as a predicate yet. 1 of the 10 devices in this family, counting this one, has a Class I recall.

  1. Root · 6 generations backK933902 Moblvac IiiAeros Instruments, Inc. · 1994 · Recalled
  2. 5 generations backK043544 Medela Dominant 35 C/I Secretion and Surgical AspiratorMedela AG · 2005
  3. 4 generations backK061205 Medela Vario 8/18/CI Secretion & Surgical AspiratorMedela AG · 2006 · Recalled
  4. 3 generations backK080212 Medela Thopaz, Model 200 0288Medela AG · 2008
  5. 2 generations backK130210 Medela ThopazMedela AG · 2013
  6. 1 generation backK141553 Medela Thopaz+Medela AG · 2014
  7. This deviceK181667 Thoraguard SystemCentese, Inc. · 2018

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K933902Moblvac IiiAeros Instruments, Inc.19941
−5K043544Medela Dominant 35 C/I Secretion and Surgical AspiratorMedela AG2005—
−4K061205Medela Vario 8/18/CI Secretion & Surgical AspiratorMedela AG20061
−3K080212Medela Thopaz, Model 200 0288Medela AG2008—
−2K130210Medela ThopazMedela AG2013—
−1K141553Medela Thopaz+Medela AG2014—
0 (this device)K181667Thoraguard SystemCentese, Inc.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200210
200411
FIG. 1 — Lineage of K181667, 1994–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new BTA device

  1. #1 K222547 Electric nasal aspiratorscore 20.7 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K141553Medela Thopaz+
Summary page 4
…ion Name: Pump, Portable, Aspiration (Manual or Powered) [21 CFR 878.4780] Regulatory Class: II Product Code: BTA 3. Predicate Device Thopaz+ Suction Pump by Medela AG (K141553) 4. Device Description The Thoraguard Surgical Drainage System is an AC/DC powered suction pump designed for the aspiration and…
Medela AG2014—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K043140Express and Oasis Chest DrainAtrium Medical Corp. · 2004 · 3 generations back · ◆ in the 2004 ancestors bar of FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 24 years and passes through 3 companies; a new generation was cleared every 4.3 years on median.
  • 3 of the 9 ancestors have a recall of any class; 1 has a Class I recall.

How does its category compare?

All BTA devices

BTA Pump, Portable, Aspiration (Manual Or Powered): FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · BTA

7so far in 2026, the most since 2007

2007: 12008: 32009: 22010: 22011: 12012: 12013: 32014: 32016: 32017: 12018: 42020: 12021: 12022: 32023: 42024: 52025: 62026 (partial year): 7
2007high 7 (2026) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · BTA

87in 2025

2008: 135 days median2013: 45 days median2014: 91 days median2016: 149 days median2018: 125 days median2022: 58 days median2023: 265 days median2024: 131 days median2025: 87 days median2026 (partial year): 89 days median
2007high 265 (2023) · low 45 (2013)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · BTA

1in 2021

2007: 12008: 32010: 32021: 1
2007high 3 (2008) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · BTA

13in 2025

2007: 132008: 52009: 142010: 1782011: 622012: 472013: 182014: 3992015: 152016: 252017: 42018: 172019: 142020: 102021: 92022: 72023: 82024: 132025: 13
2007high 399 (2014) · low 4 (2017)2025

MAUDE reports naming product code BTA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—113
2008313535
20092—014
20102—3178
20111—062
20121—047
2013345018
20143910399
20150—015
20163149025
20171—04
20184125017
20190—014
20201—010
20211—19
202235807
2023426508
20245131013
2025687013
20267890—

What is it indicated for?

The Thoraguard System is intended to be used for aspiration and removal of surgical fluids, tissue, gases, bodily fluids or infectious materials. The Thoraguard System is indicated for all situations where chest drains are applied – especially for thoracic drainage in the pleural and mediastinal cavity in situations such as pneumothorax, after cardiac or thoracic surgery (post-operative), thorax injury, pleural effusion, pleural empyema or other related conditions. The Thoraguard System is intended for use on patients in appropriate care settings.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K181667: Thoraguard System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K181667

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026